Newtricious R&D BV   Report issue

For profit Phase 3
Founded: Noord Brabant Netherlands (2006)
Status: No NME R&D (2006)

Organization Overview

First Clinical Trial
2012
NCT01694680
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

nwt-03 (3 trials)

Drugs in Other Trials (1)

xanthophyll (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Metabolic Syndrome (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 2